agonist

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴胺受体激动剂临床应疗效。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促腺激素释放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种似多巴胺的多巴胺激动剂，与第一代多巴胺激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴胺D2受体有较高的结合力。